{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:24:52Z","timestamp":1761899092806,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071952"],"award-info":[{"award-number":["81071952"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cancergen.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T02:46:32Z","timestamp":1582598792000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"243","author":[{"given":"Di","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0001","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"issue":"16","key":"10.1016\/j.cancergen.2020.02.005_bib0002","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood-2015-03-632430","article-title":"Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL","volume":"126","author":"Offner","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0003","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/107327481201900305","article-title":"Diffuse large B-Cell lymphoma: current strategies and future directions","volume":"19","author":"Cultrera","year":"2012","journal-title":"Cancer Control"},{"issue":"10053","key":"10.1016\/j.cancergen.2020.02.005_bib0004","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.cancergen.2020.02.005_bib0005","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the r-chop study in the treatment of elderly patients with diffuse large B-Cell lymphoma: a study by the groupe d'Etude des lymphomes de l'Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller","year":"2005","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.cancergen.2020.02.005_bib0007","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","article-title":"An atlas of genetic associations in UK biobank","volume":"50","author":"Canela-Xandri","year":"2018","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.cancergen.2020.02.005_bib0008","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0009","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2020.02.005_bib0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","article-title":"Five years of GWAS discovery","volume":"90","author":"Visscher","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 Years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng.3506","article-title":"Integrative approaches for large-scale transcriptome-wide association studies","volume":"48","author":"Gusev","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0014","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41467-018-03260-6","article-title":"A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis","volume":"9","author":"Theriault","year":"2018","journal-title":"Nat Commun"},{"issue":"7360","key":"10.1016\/j.cancergen.2020.02.005_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cancergen.2020.02.005_bib0016","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2020.02.005_bib0017","first-page":"1398","volume":"110","author":"Zhang","year":"2013"},{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0018","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2020.02.005_bib0019","first-page":"3879","volume":"109","author":"Lohr","year":"2012"},{"issue":"9","key":"10.1016\/j.cancergen.2020.02.005_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using David bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.cancergen.2020.02.005_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","article-title":"Bcl10 is involved in t(1;14)(p22;q32) of malt b cell lymphoma and mutated in multiple tumor types","volume":"96","author":"Willis","year":"1999","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cancergen.2020.02.005_bib0023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2559.2001.01196.x","article-title":"CD10 and BCL10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis","volume":"39","author":"Ohshima","year":"2001","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.cancergen.2020.02.005_bib0024","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/10428190290016953","article-title":"Prognostic value of BCL 10 rearrangement in diffuse large B-cell lymphoma","volume":"43","author":"Kawasaki","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.cancergen.2020.02.005_bib0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.humpath.2008.06.032","article-title":"BCL2, BCL6, MYC, malt 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome","volume":"40","author":"Tibiletti","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.cancergen.2020.02.005_bib0026","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2008.07029.x","article-title":"The human side of hypoxia-inducible factor","volume":"141","author":"Smith","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2020.02.005_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.cancergen.2020.02.005_bib0028","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1200\/JCO.2009.24.1893","article-title":"Hypoxia-Inducible factor-1 \u03b1 expression predicts superior survival in patients with diffuse large B-Cell lymphoma treated with r-chop","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.cancergen.2020.02.005_bib0029","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V112.11.479.479","article-title":"Expression of hypoxia-inducible factor (HIF) is an independent favorable prognostic factor in diffuse large B-Cell lymphoma (DLBCL) treated with r-chop","volume":"112","author":"Evens","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cancergen.2020.02.005_bib0030","doi-asserted-by":"crossref","first-page":"e81333","DOI":"10.1371\/journal.pone.0081333","article-title":"Paradoxical regulation of hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) by histone deacetylase inhibitor in diffuse large B-Cell lymphoma","volume":"8","author":"Bhalla","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.cancergen.2020.02.005_bib0031","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cancergen.2020.02.005_bib0032","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2006.06210.x","article-title":"Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab","volume":"134","author":"Wanner","year":"2006","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.cancergen.2020.02.005_bib0033","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00277-013-1770-9","article-title":"Activation of the PI3K\/AKT\/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab","volume":"92","author":"Xu","year":"2013","journal-title":"Ann Hematol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776220301381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776220301381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:48Z","timestamp":1761896628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776220301381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":33,"alternative-id":["S2210776220301381"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2020.02.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}